National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, PR China.
National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, PR China.
Int J Biol Macromol. 2020 Jul 1;154:835-843. doi: 10.1016/j.ijbiomac.2020.03.161. Epub 2020 Mar 17.
It is of great clinical significance to design wound dressing materials with combined excellent wound healing properties and superior capability to suppress hypertrophic scar formation. This study aimed to examine if and how the cationicity of chitosan would affect the hypertrophic scar-related outcomes, through preparing carboxymethyl chitosan hydrogels with different genipin concentrations (2.5%, 5%, 10% and 15%, respectively). An optimum window of chitosan cationicity (5% in our case) demonstrated potential to mitigate hypertrophic scar in wound healing by suppressing the expression of a-smooth muscle actin (a-SMA) and promoting secretion of type I matrix metalloproteinases (MMP-1). In vivo, the CMCS-5% hydrogel again showed smaller, thinner and smoother wound appearance. Moreover, the CMCS-5% sample with additional incorporation of 2% (V/V) Aloe vera gel exhibited further improved performance in scar inhibition. Overall, such findings might have important implications in chitosan-based wound dressing design for high-quality wound repair and effective scar inhibition.
设计兼具优异伤口愈合性能和卓越抑制增生性瘢痕形成能力的创面敷料材料具有重要的临床意义。本研究旨在通过制备不同浓度京尼平(分别为 2.5%、5%、10%和 15%)的羧甲基壳聚糖水凝胶,探讨壳聚糖的正电荷性是否以及如何影响与增生性瘢痕相关的结果。结果表明,壳聚糖的最佳正电荷窗口(在我们的研究中为 5%)具有通过抑制α-平滑肌肌动蛋白(α-SMA)的表达和促进 I 型基质金属蛋白酶(MMP-1)的分泌来减轻伤口愈合中增生性瘢痕的潜力。在体内,CMCS-5%水凝胶再次显示出更小、更薄和更光滑的伤口外观。此外,CMCS-5%样品中额外添加 2%(V/V)的芦荟凝胶,在抑制瘢痕方面表现出进一步的改善性能。总之,这些发现可能对基于壳聚糖的创面敷料设计具有重要意义,有助于实现高质量的伤口修复和有效的瘢痕抑制。